Key result
Beta-1-adrenergic receptor autoantibodies are relatively prevalent in dilated cardiomyopathies and are being prospectively investigated in the ongoing ETiCS study.
Answers are grounded in this paper and cite their sources.
Discusses the potential pathophysiologic role of beta-1-adrenergic receptor autoantibodies in heart failure and the prospect of aptamer therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Port et al. (2011) conducted an editorial in Heart failure. Beta-1-adrenergic receptor autoantibodies was evaluated. Beta-1-adrenergic receptor autoantibodies are relatively prevalent in dilated cardiomyopathies and are being prospectively investigated in the ongoing ETiCS study.
Synapse has enriched 10 related papers. Consider them for comparative context: